Treatment of orbital inflammation with rituximab in Wegener's granulomatosis

Bo Baslund, Anne Katrine Wiencke, Niels Rasmussen, Mikkel Faurschou, Peter Bjerre Toft

19 Citations (Scopus)


To study the efficacy of rituximab therapy for the treatment of orbital inflammation in patients with Wegener's granulomatosis (WG).
Original languageEnglish
JournalClinical and Experimental Rheumatology
Issue number1 Suppl 70
Pages (from-to)S7-10
Publication statusPublished - 2012


  • Adult
  • Aged
  • Antibodies, Monoclonal, Murine-Derived
  • Denmark
  • Female
  • Humans
  • Immunologic Factors
  • Inflammation
  • Male
  • Middle Aged
  • Orbital Diseases
  • Physical Examination
  • Recovery of Function
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Visual Acuity
  • Wegener Granulomatosis
  • Young Adult


Dive into the research topics of 'Treatment of orbital inflammation with rituximab in Wegener's granulomatosis'. Together they form a unique fingerprint.

Cite this